Heterocyclyl pyrazolopyrimidine analogues as selective JAK inhibitors
AssigneeCellzome Limited
InventorsKathryn Bell, Nelly Piton, Claudio Dagostin, Cyrille Boussard, Andrew Ratcliffe, Nigel Ramsden
Life of this patent
Estimating the term…
Loading patent…
AssigneeCellzome Limited
InventorsKathryn Bell, Nelly Piton, Claudio Dagostin, Cyrille Boussard, Andrew Ratcliffe, Nigel Ramsden
Estimating the term…
The present invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
A compound of the structure:
A compound of the structure:
A pharmaceutically acceptable salt of a compound of the structure:
Dependencies are inferred from the claim text.